EcoDrugPlus

Adenosine Receptor A1-Like

Ensembl ID : ENSNFUG00015013772
Gene Symbol: LOC107385566
3 Cross references
204 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSNFUG00015005134
Gene Symbol: LOC107384929
2 Cross references
145 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSNFUG00015015836
Gene Symbol: ADRM1
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSNFUG00015012777
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSNFUG00015001279
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSNFUG00015010165
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSNFUG00015009424
Gene Symbol: ADRA2A
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSNFUG00015005474
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSNFUG00015011327
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSNFUG00015005319
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSNFUG00015012887
Gene Symbol: AKR1B1
3 Cross references
345 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSNFUG00015012832
Gene Symbol: AKR1B1
1 Cross references
343 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).